Mandate

Vinge advises SBB in connection with its sale to Brookfield

Vinge advises Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB") in connection with its sale of stake in its social infrastructure portfolio for public education to Brookfield for SEK 9.2 billion. The transaction also includes earn out payments up to SEK 1.2 billion.

SBB contributes its SEK 44.9 billion social infrastructure portfolio for public education to a newly formed SBB subsidiary EduCo AB (“EduCo”). Brookfield, one of the world’s largest infrastructure investors, through its open-ended core infrastructure fund (Brookfield Super-Core Infrastructure Partners), acquires a 49% minority stake in EduCo from SBB for approx. SEK 9.2 billion in cash up front, plus up to approx. SEK 1.2 billion in cash through earn-outs. EduCo will be operated and managed by SBB through an asset management agreement with respect to the management of the EduCo portfolio in its entirety.

Vinge’s team consisted of Jesper Schönbeck, Rikard Lindahl and Joel Wahlberg (Capital markets and Public M&A), Niclas Winnberg, Karolina Cohrs, Frida Ställborn, Kristoffer Larsson and Anette Kahn (Real Estate and Social Infrastructure), Albert Wållgren, Linn Adelwald and Axel Jansson (Financing), Maria Dahlin Kolvik and Sebastian Saadieh (M&A), Marcus Glader and Trine Osen Bergqvist (Competition and Regulatory) and Robert Wikholm (Restructuring and Insolvency).

 

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026